Senolytic and anti-fibrotic agents (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Senolytic and anti-fibrotic agents (investigational), covering 2024-04-16 to 2024-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis [Phase 1, Phase 2]